カテゴリー： Allied Market Research, 世界, 医療/バイオ

迷走神経刺激療法（VNS）の世界市場2023-2032：機会分析・産業予測

◆英語タイトル：Vagus Nerve Stimulation Market By Product (Implantable VNS devices, External VNS devices), By Application (Epilepsy, Depression, Others), By End user (Hospitals, Neurology clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Allied Market Researchが発行した調査報告書（ALD23SEP110）◆商品コード：ALD23SEP110
◆発行会社（リサーチ会社）：Allied Market Research
◆発行日：2023年4月
◆ページ数：233
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：生命科学
◆販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

迷走神経刺激療法（VNS）の世界市場規模は、2022年に4億8850万ドルと評価され、2023年から2032年までの年平均成長率は5.5%で、2032年には8億3610万ドルに達すると予測されています。迷走神経刺激療法（VNS）は、脳幹から腹部まで走る太い神経である迷走神経を電気インパルスで刺激する医療行為です。迷走神経は、心拍数、消化、呼吸など、多くの重要な生理機能を調節する役割を担っています。植込み型デバイスは通常、胸部または頸部の皮下に植え込まれ、迷走神経にワイヤーが取り付けられます。この装置から発生する電気インパルスは、心拍数、呼吸、消化など、体内のさまざまな生理機能を調節するのに役立ちます。迷走神経刺激療法（VNS）は現在、てんかん、うつ病、片頭痛など、いくつかの疾患の治療に用いられています。

迷走神経刺激療法（VNS）は一般的に安全で忍容性が高いと考えられていますが、嗄声、咳、声の変化、首の痛みなどの副作用もあります。これらの装置には、植え込み型迷走神経刺激療法（VNS）装置と外部迷走神経刺激療法（VNS）装置の2種類があります。迷走神経刺激療法（VNS）は、てんかんやうつ病の治療薬としてFDAに承認されています。また、従来の薬物療法と比較して、神経の電気刺激は、標的を絞った調節可能な刺激、全身的な副作用のリスクの低減、長期的な効果の可能性など、いくつかの利点を提供することができます。
迷走神経刺激療法（VNS）の世界市場は、てんかんに苦しむ人々の増加と迷走神経刺激療法（VNS）デバイスの技術的進歩の上昇が主な要因です。例えば、2021年に米国疾病予防管理センター（CDC）は、世界中で成人の5％がうつ病を患っていると推定しています。したがって、てんかん、うつ病、慢性疼痛などの慢性疾患の有病率の増加が、疾患を管理および治療するための迷走神経刺激療法（VNS）デバイスの需要を促進しています。

しかし、迷走神経刺激療法（VNS）装置に関連する高額な費用や、一部の国では熟練した人材が不足していることが、市場の成長をある程度妨げています。さらに、低開発国の多くの人々は迷走神経刺激療法（VNS）療法の重要性を認識しておらず、これらの治療法の潜在的な利点を理解していません。
さらに、迷走神経刺激療法（VNS）装置の開発と技術の進歩は、予測期間中にアジア太平洋地域とLAMEA地域の新興経済圏に成長機会を提供します。患者のニーズに基づいて刺激を調整する低侵襲デバイスや閉ループシステムの開発など、迷走神経刺激療法（VNS）技術の進歩は著しいものがあります。例えば、Soterix Medical Inc.は、必要なパルスパラメータ設定を提供し、迷走神経系を変調させるポータブルオプションを提供する初の経皮耳介迷走神経刺激療法（VNS）装置を発表しました。このような技術的進歩により、迷走神経刺激療法（VNS）治療の有効性とアクセシビリティが向上し、市場成長の原動力になると期待されています。さらに、医療提供者や患者の間で、さまざまな症状を治療するための迷走神経刺激療法（VNS）の利点に対する認識が高まっていることが、迷走神経刺激療法（VNS）デバイスの需要をさらに促進しています。

迷走神経刺激療法（VNS）の世界市場は、製品、用途、エンドユーザー、地域に区分されます。製品別では、植え込み型迷走神経刺激療法（VNS）装置と外付け迷走神経刺激療法（VNS）装置に分類されます。用途別では、てんかん、うつ病、その他に分類されます。エンドユーザー別では、病院、神経クリニック、その他に分類されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他の欧州地域）、アジア太平洋地域（日本、中国、インド、オーストラリア、韓国、その他のアジア太平洋地域）、LAMEA（ブラジル、南アフリカ、サウジアラビア、その他のLAMEA地域）で分析されています。
迷走神経刺激療法（VNS）の世界市場で事業を展開する主な主要企業は、Beijing PINS Medical Co.Ltd.、Cirtec、electroCore, Inc.、LivaNova PLC、MicroTransponder Inc.、t迷走神経刺激療法（VNS） Health GmbH、Parasym Ltd.、Neuropix Company Ltd.、Soterix Medical Inc.、SetPoint Medicalです。

ステークホルダーにとっての主なメリット
この調査レポートは、迷走神経刺激療法（VNS）市場の市場機会を特定するために、2022年から2032年までの迷走神経刺激療法（VNS）市場分析の市場セグメント、現在の動向、予測、ダイナミクスの定量的分析を提供します。
主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
迷走神経刺激療法（VNS）市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
迷走神経刺激療法（VNS）の地域別および世界市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

主要市場セグメント
製品別
埋め込み型迷走神経刺激療法（VNS）装置
体外式迷走神経刺激療法（VNS）装置

用途別
てんかん
うつ病
その他

エンドユーザー別
病院
神経内科クリニック
その他

地域別
北米
米国
カナダ
メキシコ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
アジア太平洋
日本
中国
インド
オーストラリア
韓国
その他のアジア太平洋地域
LAMEA
ラテンアメリカ
中東・アフリカ

主な市場プレイヤー
○ Beijing PINS Medical Co., Ltd
○ electroCore, Inc.
○ LivaNova PLC
○ MicroTransponder Inc.
○ Neuropix Company Ltd.
○ Parasym Ltd
○ SetPoint Medical Corporation
○ Soterix Medical Inc.
○ t迷走神経刺激療法（VNS） Health GmbH

第1章：イントロダクション
第2章：エグゼクティブサマリー
第3章：市場概要
第4章：迷走神経刺激療法（VNS）市場、製品別
第5章：迷走神経刺激療法（VNS）市場、用途別
第6章：迷走神経刺激療法（VNS）市場、エンドユーザー別
第7章：迷走神経刺激療法（VNS）市場、地域別
第8章：競争状況
第9章：企業情報

❖ レポートの目次 ❖

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence and incidence of epilepsy
3.4.1.2. Rise in demand for minimally invasive devices
3.4.1.3. Initiatives by government and non-government organizations

3.4.2. Restraints
3.4.2.1. High cost of vagus nerve stimulation devices

3.4.3. Opportunities
3.4.3.1. Rise in technological advancements

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: VAGUS NERVE STIMULATION MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Implantable 迷走神経刺激療法（VNS） devices
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. External 迷走神経刺激療法（VNS） devices
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: VAGUS NERVE STIMULATION MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Epilepsy
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Depression
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: VAGUS NERVE STIMULATION MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Neurology clinics
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: VAGUS NERVE STIMULATION MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Product
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End user
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Product
7.2.5.1.3. Market size and forecast, by Application
7.2.5.1.4. Market size and forecast, by End user
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Product
7.2.5.2.3. Market size and forecast, by Application
7.2.5.2.4. Market size and forecast, by End user
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Product
7.2.5.3.3. Market size and forecast, by Application
7.2.5.3.4. Market size and forecast, by End user
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Product
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End user
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Product
7.3.5.1.3. Market size and forecast, by Application
7.3.5.1.4. Market size and forecast, by End user
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Product
7.3.5.2.3. Market size and forecast, by Application
7.3.5.2.4. Market size and forecast, by End user
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Product
7.3.5.3.3. Market size and forecast, by Application
7.3.5.3.4. Market size and forecast, by End user
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Product
7.3.5.4.3. Market size and forecast, by Application
7.3.5.4.4. Market size and forecast, by End user
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Product
7.3.5.5.3. Market size and forecast, by Application
7.3.5.5.4. Market size and forecast, by End user
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Product
7.3.5.6.3. Market size and forecast, by Application
7.3.5.6.4. Market size and forecast, by End user
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Product
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End user
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Product
7.4.5.1.3. Market size and forecast, by Application
7.4.5.1.4. Market size and forecast, by End user
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Product
7.4.5.2.3. Market size and forecast, by Application
7.4.5.2.4. Market size and forecast, by End user
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Product
7.4.5.3.3. Market size and forecast, by Application
7.4.5.3.4. Market size and forecast, by End user
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Product
7.4.5.4.3. Market size and forecast, by Application
7.4.5.4.4. Market size and forecast, by End user
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Product
7.4.5.5.3. Market size and forecast, by Application
7.4.5.5.4. Market size and forecast, by End user
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Product
7.4.5.6.3. Market size and forecast, by Application
7.4.5.6.4. Market size and forecast, by End user
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Product
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End user
7.5.5. Market size and forecast, by country
7.5.5.1. Latin America
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Product
7.5.5.1.3. Market size and forecast, by Application
7.5.5.1.4. Market size and forecast, by End user
7.5.5.2. Middle East And Africa
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Product
7.5.5.2.3. Market size and forecast, by Application
7.5.5.2.4. Market size and forecast, by End user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. electroCore, Inc.
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. LivaNova PLC
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. MicroTransponder Inc.
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.4. Neuropix Company Ltd.
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. Parasym Ltd
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. Soterix Medical Inc.
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. t迷走神経刺激療法（VNS） Health GmbH
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Beijing PINS Medical Co., Ltd
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. SetPoint Medical Corporation
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio

LIST OF TABLES
TABLE 01. GLOBAL VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 02. VAGUS NERVE STIMULATION MARKET FOR IMPLANTABLE VNS DEVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 03. VAGUS NERVE STIMULATION MARKET FOR EXTERNAL VNS DEVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 05. VAGUS NERVE STIMULATION MARKET FOR EPILEPSY, BY REGION, 2022-2032 ($MILLION)
TABLE 06. VAGUS NERVE STIMULATION MARKET FOR DEPRESSION, BY REGION, 2022-2032 ($MILLION)
TABLE 07. VAGUS NERVE STIMULATION MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 08. GLOBAL VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 09. VAGUS NERVE STIMULATION MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. VAGUS NERVE STIMULATION MARKET FOR NEUROLOGY CLINICS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. VAGUS NERVE STIMULATION MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. VAGUS NERVE STIMULATION MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 13. NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 14. NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 15. NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 17. U.S. VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 18. U.S. VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 19. U.S. VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 20. CANADA VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 21. CANADA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 22. CANADA VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 23. MEXICO VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 24. MEXICO VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 25. MEXICO VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 26. EUROPE VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 27. EUROPE VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 28. EUROPE VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. EUROPE VAGUS NERVE STIMULATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 30. GERMANY VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 31. GERMANY VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 32. GERMANY VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 33. FRANCE VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 34. FRANCE VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 35. FRANCE VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 36. UK VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 37. UK VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 38. UK VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 39. ITALY VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 40. ITALY VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 41. ITALY VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. SPAIN VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 43. SPAIN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 44. SPAIN VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 45. REST OF EUROPE VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 46. REST OF EUROPE VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 47. REST OF EUROPE VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 49. ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 50. ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 52. JAPAN VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 53. JAPAN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 54. JAPAN VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 55. CHINA VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 56. CHINA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 57. CHINA VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 58. INDIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 59. INDIA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 60. INDIA VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 62. AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 64. SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 65. SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 66. SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 70. LAMEA VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 71. LAMEA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 72. LAMEA VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. LAMEA VAGUS NERVE STIMULATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 74. LATIN AMERICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 75. LATIN AMERICA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 76. LATIN AMERICA VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 77. MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 78. MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 79. MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 80. ELECTROCORE, INC.: KEY EXECUTIVES
TABLE 81. ELECTROCORE, INC.: COMPANY SNAPSHOT
TABLE 82. ELECTROCORE, INC.: PRODUCT SEGMENTS
TABLE 83. ELECTROCORE, INC.: PRODUCT PORTFOLIO
TABLE 84. ELECTROCORE, INC.: KEY STRATERGIES
TABLE 85. LIVANOVA PLC: KEY EXECUTIVES
TABLE 86. LIVANOVA PLC: COMPANY SNAPSHOT
TABLE 87. LIVANOVA PLC: PRODUCT SEGMENTS
TABLE 88. LIVANOVA PLC: PRODUCT PORTFOLIO
TABLE 89. LIVANOVA PLC: KEY STRATERGIES
TABLE 90. MICROTRANSPONDER INC.: KEY EXECUTIVES
TABLE 91. MICROTRANSPONDER INC.: COMPANY SNAPSHOT
TABLE 92. MICROTRANSPONDER INC.: PRODUCT SEGMENTS
TABLE 93. MICROTRANSPONDER INC.: PRODUCT PORTFOLIO
TABLE 94. NEUROPIX COMPANY LTD.: KEY EXECUTIVES
TABLE 95. NEUROPIX COMPANY LTD.: COMPANY SNAPSHOT
TABLE 96. NEUROPIX COMPANY LTD.: PRODUCT SEGMENTS
TABLE 97. NEUROPIX COMPANY LTD.: PRODUCT PORTFOLIO
TABLE 98. PARASYM LTD: KEY EXECUTIVES
TABLE 99. PARASYM LTD: COMPANY SNAPSHOT
TABLE 100. PARASYM LTD: PRODUCT SEGMENTS
TABLE 101. PARASYM LTD: PRODUCT PORTFOLIO
TABLE 102. SOTERIX MEDICAL INC.: KEY EXECUTIVES
TABLE 103. SOTERIX MEDICAL INC.: COMPANY SNAPSHOT
TABLE 104. SOTERIX MEDICAL INC.: PRODUCT SEGMENTS
TABLE 105. SOTERIX MEDICAL INC.: PRODUCT PORTFOLIO
TABLE 106. TVNS HEALTH GMBH: KEY EXECUTIVES
TABLE 107. TVNS HEALTH GMBH: COMPANY SNAPSHOT
TABLE 108. TVNS HEALTH GMBH: PRODUCT SEGMENTS
TABLE 109. TVNS HEALTH GMBH: PRODUCT PORTFOLIO
TABLE 110. BEIJING PINS MEDICAL CO., LTD: KEY EXECUTIVES
TABLE 111. BEIJING PINS MEDICAL CO., LTD: COMPANY SNAPSHOT
TABLE 112. BEIJING PINS MEDICAL CO., LTD: PRODUCT SEGMENTS
TABLE 113. BEIJING PINS MEDICAL CO., LTD: PRODUCT PORTFOLIO
TABLE 114. SETPOINT MEDICAL CORPORATION: KEY EXECUTIVES
TABLE 115. SETPOINT MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 116. SETPOINT MEDICAL CORPORATION: PRODUCT SEGMENTS
TABLE 117. SETPOINT MEDICAL CORPORATION: PRODUCT PORTFOLIO

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 迷走神経刺激療法（VNS）の世界市場2023-2032：機会分析・産業予測(Vagus Nerve Stimulation Market By Product (Implantable VNS devices, External VNS devices), By Application (Epilepsy, Depression, Others), By End user (Hospitals, Neurology clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 化学療法誘発性貧血（CIA）の世界市場2023-2032：機会分析・産業予測
  • セルカウント（細胞計数）の世界市場2023-2032：機会分析・産業予測
  • 医療情報交換（HIE）の世界市場2023-2032：機会分析・産業予測
  • ビルエネルギーマネジメントシステム（BEMS）の世界市場2023-2032：機会分析・産業予測
  • 温度制御システム（TCS）の世界市場2023-2032：機会分析・産業予測

    • ◆H&Iグローバルリサーチのお客様（例）◆